Go Pro
→ BofA: Digital Dollar Coming 2025-2030 (From Decentralized Masters) (Ad)tc pixel Free EDEN Stock Alerts

Eden Research (EDEN) Competitors

Eden Research logo
GBX 2.68 -0.22 (-7.59%)
As of 07/24/2026 10:47 AM Eastern
Compare

EDEN vs. WYN, DNK, PHC, EML, and KRPZ

Should you buy Eden Research stock or one of its competitors? MarketBeat compares Eden Research with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Eden Research include Wynnstay Group (WYN), Danakali (DNK), Plant Health Care (PHC), Emmerson (EML), and Kropz (KRPZ). These companies are all part of the "agricultural inputs" industry.

How does Eden Research compare to Wynnstay Group?

Eden Research (LON:EDEN) and Wynnstay Group (LON:WYN) are both small-cap basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends.

In the previous week, Wynnstay Group had 2 more articles in the media than Eden Research. MarketBeat recorded 2 mentions for Wynnstay Group and 0 mentions for Eden Research. Wynnstay Group's average media sentiment score of 0.93 beat Eden Research's score of 0.00 indicating that Wynnstay Group is being referred to more favorably in the news media.

Company Overall Sentiment
Eden Research Neutral
Wynnstay Group Positive

Wynnstay Group has a consensus target price of GBX 500, suggesting a potential upside of 35.50%. Given Wynnstay Group's stronger consensus rating and higher probable upside, analysts plainly believe Wynnstay Group is more favorable than Eden Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Eden Research
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Wynnstay Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Wynnstay Group has a net margin of 0.51% compared to Eden Research's net margin of -44.31%. Wynnstay Group's return on equity of 2.23% beat Eden Research's return on equity.

Company Net Margins Return on Equity Return on Assets
Eden Research-44.31% -15.05% -11.29%
Wynnstay Group 0.51%2.23%2.08%

13.5% of Eden Research shares are held by institutional investors. Comparatively, 5.9% of Wynnstay Group shares are held by institutional investors. 3.2% of Eden Research shares are held by insiders. Comparatively, 4.2% of Wynnstay Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Wynnstay Group has higher revenue and earnings than Eden Research. Eden Research is trading at a lower price-to-earnings ratio than Wynnstay Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eden Research£3.62M5.96-£1.52M-£0.44N/A
Wynnstay Group£582.60M0.15£6.20M£11.9031.01

Eden Research has a beta of 1.813, indicating that its share price is 81% more volatile than the broader market. Comparatively, Wynnstay Group has a beta of 0.199, indicating that its share price is 80% less volatile than the broader market.

Summary

Wynnstay Group beats Eden Research on 13 of the 16 factors compared between the two stocks.

How does Eden Research compare to Danakali?

Eden Research (LON:EDEN) and Danakali (LON:DNK) are both small-cap basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

In the previous week, Eden Research's average media sentiment score of 0.00 equaled Danakali'saverage media sentiment score.

Company Overall Sentiment
Eden Research Neutral
Danakali Neutral

Danakali has a net margin of 0.00% compared to Eden Research's net margin of -44.31%. Danakali's return on equity of 0.00% beat Eden Research's return on equity.

Company Net Margins Return on Equity Return on Assets
Eden Research-44.31% -15.05% -11.29%
Danakali N/A N/A N/A

13.5% of Eden Research shares are held by institutional investors. 3.2% of Eden Research shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Danakali has lower revenue, but higher earnings than Eden Research. Eden Research is trading at a lower price-to-earnings ratio than Danakali, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eden Research£3.62M5.96-£1.52M-£0.44N/A
Danakali£67.50K0.00N/A-£1.10N/A

Summary

Eden Research beats Danakali on 5 of the 8 factors compared between the two stocks.

How does Eden Research compare to Plant Health Care?

Plant Health Care (LON:PHC) and Eden Research (LON:EDEN) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

Plant Health Care has a net margin of -35.69% compared to Eden Research's net margin of -44.31%. Eden Research's return on equity of -15.05% beat Plant Health Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Plant Health Care-35.69% -40.17% -20.92%
Eden Research -44.31%-15.05%-11.29%

Plant Health Care has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market. Comparatively, Eden Research has a beta of 1.813, indicating that its share price is 81% more volatile than the broader market.

Eden Research has lower revenue, but higher earnings than Plant Health Care. Eden Research is trading at a lower price-to-earnings ratio than Plant Health Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Plant Health Care£11.21M0.00-£4M-£0.01N/A
Eden Research£3.62M5.96-£1.52M-£0.44N/A

In the previous week, Plant Health Care's average media sentiment score of 0.00 equaled Eden Research'saverage media sentiment score.

Company Overall Sentiment
Plant Health Care Neutral
Eden Research Neutral

24.0% of Plant Health Care shares are held by institutional investors. Comparatively, 13.5% of Eden Research shares are held by institutional investors. 72.2% of Plant Health Care shares are held by company insiders. Comparatively, 3.2% of Eden Research shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Plant Health Care and Eden Research tied by winning 5 of the 10 factors compared between the two stocks.

How does Eden Research compare to Emmerson?

Emmerson (LON:EML) and Eden Research (LON:EDEN) are both small-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and media sentiment.

Eden Research has higher revenue and earnings than Emmerson. Eden Research is trading at a lower price-to-earnings ratio than Emmerson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EmmersonN/AN/A-£4.50M-£2.27N/A
Eden Research£3.62M5.96-£1.52M-£0.44N/A

Emmerson has a net margin of 0.00% compared to Eden Research's net margin of -44.31%. Emmerson's return on equity of 478.72% beat Eden Research's return on equity.

Company Net Margins Return on Equity Return on Assets
EmmersonN/A 478.72% -7.75%
Eden Research -44.31%-15.05%-11.29%

In the previous week, Emmerson had 3 more articles in the media than Eden Research. MarketBeat recorded 3 mentions for Emmerson and 0 mentions for Eden Research. Emmerson's average media sentiment score of 0.21 beat Eden Research's score of 0.00 indicating that Emmerson is being referred to more favorably in the media.

Company Overall Sentiment
Emmerson Neutral
Eden Research Neutral

6.6% of Emmerson shares are owned by institutional investors. Comparatively, 13.5% of Eden Research shares are owned by institutional investors. 7.3% of Emmerson shares are owned by insiders. Comparatively, 3.2% of Eden Research shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Emmerson has a beta of 1.319, meaning that its stock price is 32% more volatile than the broader market. Comparatively, Eden Research has a beta of 1.813, meaning that its stock price is 81% more volatile than the broader market.

Summary

Emmerson beats Eden Research on 7 of the 12 factors compared between the two stocks.

How does Eden Research compare to Kropz?

Eden Research (LON:EDEN) and Kropz (LON:KRPZ) are both small-cap basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

Eden Research has higher earnings, but lower revenue than Kropz. Eden Research is trading at a lower price-to-earnings ratio than Kropz, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eden Research£3.62M5.96-£1.52M-£0.44N/A
Kropz£38.52M0.38-£137.40M£0.781.15

Kropz has a net margin of 13.33% compared to Eden Research's net margin of -44.31%. Kropz's return on equity of 7.17% beat Eden Research's return on equity.

Company Net Margins Return on Equity Return on Assets
Eden Research-44.31% -15.05% -11.29%
Kropz 13.33%7.17%-7.02%

Eden Research has a beta of 1.813, indicating that its share price is 81% more volatile than the broader market. Comparatively, Kropz has a beta of 0.405, indicating that its share price is 60% less volatile than the broader market.

In the previous week, Eden Research's average media sentiment score of 0.00 equaled Kropz'saverage media sentiment score.

Company Overall Sentiment
Eden Research Neutral
Kropz Neutral

13.5% of Eden Research shares are held by institutional investors. 3.2% of Eden Research shares are held by company insiders. Comparatively, 3.6% of Kropz shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Kropz beats Eden Research on 7 of the 11 factors compared between the two stocks.

Get Eden Research News Delivered to You Automatically

Sign up to receive the latest news and ratings for EDEN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EDEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EDEN vs. The Competition

Export
MetricEden ResearchAgricultural Inputs IndustryMaterials SectorLON Exchange
Market Cap£21.69M£4.72B£4.58B£2.64B
Dividend YieldN/A2.47%5.02%6.15%
P/E Ratio-6.0510.5221.09368.39
Price / Sales5.9689.095,743.8784,479.14
Price / Cash11.9016.5726.3027.89
Price / Book1.120.978.577.41
Net Income-£1.52M£62.49M£157.08M£5.89B
7 Day Performance-7.59%-1.45%1.19%0.39%
1 Month Performance-11.55%-2.72%-1.61%0.27%
1 Year Performance-23.34%4.18%35.52%68.12%

Eden Research Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EDEN
Eden Research
N/AGBX 2.68
-7.6%		N/A-23.3%£21.69M£3.62MN/A19
WYN
Wynnstay Group
4.5849 of 5 stars		GBX 368.28
+1.5%		GBX 500
+35.8%		+1.1%£84.77M£582.60M30.95944
DNK
Danakali
N/AN/AN/AN/A£73.67M£67.50KN/A5,205
PHC
Plant Health Care
N/AN/AN/AN/A£32.50M£11.21MN/A56
EML
Emmerson
N/AGBX 1.84
-3.4%		N/A+1.1%£24.52MN/AN/A1,190

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:EDEN) was last updated on 7/26/2026 by MarketBeat.com Staff.
From Our Partners
The pact that ran the world and dollar just expired
In 1974, a U.S.-Saudi deal tied oil sales exclusively to dollars, forcing nations worldwide to hold dollars an...
Golden Portfolio | Sponsoredtc pixel
The comeback story of the century (ticker inside)
In 2013, this struggling PC maker went private amid skepticism from Forbes and the New York Times. Instead of ...
InvestorPlace | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Universal basic income is not impossible. It exist (kind of)
Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...
Freedom Financial | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
The invention Elon called the greatest in history
Jeff Brown and Marc Chaikin - two investors who called Nvidia a decade ago - say Elon Musk's newly filed AI pa...
Brownstone Research | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel